MARKET

CDT

CDT

Conduit Pharms
NASDAQ
0.7792
-0.0018
-0.23%
Opening 14:38 04/01 EDT
OPEN
0.8321
PREV CLOSE
0.7810
HIGH
0.9700
LOW
0.7500
VOLUME
2.88M
TURNOVER
--
52 WEEK HIGH
379.00
52 WEEK LOW
0.7250
MARKET CAP
4.83M
P/E (TTM)
-4.5621
1D
5D
1M
3M
1Y
5Y
1D
Biotech Alert: Searches spiking for these stocks today
TipRanks · 1d ago
Conduit Pharmaceuticals receives U.S. patent approval for AZD1656
TipRanks · 1d ago
CONDUIT PHARMACEUTICALS INC - SECURES COMPOSITION OF MATTER PATENT FROM USPTO FOR AZD1656
Reuters · 1d ago
CONDUIT PHARMACEUTICALS INC - SECURES 20 YEARS OF PATENT PROTECTION FOR AZD1656 IN U.S.
Reuters · 1d ago
Conduit Pharmaceuticals Awarded U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
Benzinga · 1d ago
Weekly Report: what happened at CDT last week (0324-0328)?
Weekly Report · 1d ago
Weekly Report: what happened at CDT last week (0317-0321)?
Weekly Report · 03/24 12:11
CONDUIT PHARMACEUTICALS PROVIDES RESEARCH AND DEVELOPMENT UPDATE ON PROGRESS FOR PIPELINE ASSETS AZD1656, AZD5658, AND AZD5904
Reuters · 03/19 12:30
More
About CDT
More
Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company’s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto’s Thyroiditis. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto’s Thyroiditis (HT and Graves’ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto’s Thyroiditis and Graves’ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI).
Recently
Symbol
Price
%Change
    CDT
  • 0.7792
  • -0.23%

Webull offers Conduit Pharmaceuticals Inc stock information, including NASDAQ: CDT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDT stock methods without spending real money on the virtual paper trading platform.